JUL 15, 2020 5:09 PM PDT

Immune Memory to Thwart Recurring Cancer

WRITTEN BY: Kara Marker

Preventing cancer from returning in the body is an integral part of any anti-cancer treatment plan. New discoveries from a research group out of the University of Pittsburgh highlight an important protein involved in releasing the immune system to use all of its power to prevent recurring bouts of cancer.

"Our findings point to an important new biological anti-tumor mechanism that we can exploit to provide durable, long-term immune response against tumors,” explained Dario A.A. Vignali, PhD.

The mechanism he mentions is the relationship between the newly studied Neuropilin-1 (NRP1) protein and effector T cells responsible for targeting and destroying cancerous cells in the body. At the beginning of this study, researchers hypothesized that NRP1 might be a vital component of immune suppression in response to cancer.

Why would the body suppress the immune response to cancer at all? The immune system has regulatory mechanisms in place to prevent the immune system from overreacting to stimuli, but in the case of cancer, researchers want to give the immune system all the power it can get. This is the foundational idea behind immunotherapy.

Immunotherapy that targets cancer works by blocking checkpoint inhibitor proteins, giving effector T cells an all-access pass to targeting cancer cells. The problem? Two-thirds of patients don’t respond to this type of treatment. There needs to be a way to increase the number of people who can be helped by immunotherapy, and NRP1 may be the key.

Going into the study, researchers were familiar with NRP1 on surface of non-effector T cells, but the activity of NRP1 related to effector T cells was unclear. They used a mouse model - genetically modified to lack NRP1 from the surface of effector T cells – to see what would happen after grafting tumor cells to the mouse model.

While they expected the tumors to grow little to not at all compared to control mice with fully functional NRP1, instead they saw zero difference in tumor growth between experimental and control. However, when researchers mimicked cancer recurrence by removing the original tumor cells and grafting them elsewhere, NRP1-deficient mice showed significantly less tumor growth compared to control mice.

This stark difference showed the researchers that NRP1 is fundamental for T cell development and immune memory. T cells with NRP1 intact on their cell surface became “exhausted and ineffective in fighting cancer,” especially when the battle continued for a long time.

Removing NRP1 from the cell surface boosted immune memory, explaining why when the same tumor cells were grafted for a second time but in a different location in the mouse models lacking NRP1 on effector T cells, the mice were exceptionally successful at suppressing further growth.

Interestingly, these findings correspond with studies of human T cells extracted from the blood in cases of skin cancer or cancer in the head or neck. Advanced cancer patients exhibited higher levels of NRP1 on so-called “memory” effector T cells compared to early-stage cancer patients.

Drugs targeted NRP1 are currently being tested in combination with anti-PD1 immunotherapies.

Sources: University of Pittsburgh, Nature Immunology

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 28, 2020
Genetics & Genomics
Why Some Young, Healthy People Get Severe COVID-19
SEP 28, 2020
Why Some Young, Healthy People Get Severe COVID-19
Since the start of the pandemic, scientists have been trying to find out why some people get such severe illness from SA ...
OCT 24, 2020
Immunology
New CRISPR-Based Imaging Tool Is Going to Be HiUGE
OCT 24, 2020
New CRISPR-Based Imaging Tool Is Going to Be HiUGE
A team of researchers at Duke University have developed an imaging technology for tagging structures at a cellular level ...
NOV 12, 2020
Health & Medicine
Measles Cases and Deaths Surge Worldwide
NOV 12, 2020
Measles Cases and Deaths Surge Worldwide
Today, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) released a stat ...
DEC 17, 2020
Immunology
A Peanut a Day Keeps Allergies Away
DEC 17, 2020
A Peanut a Day Keeps Allergies Away
Canadian researchers have made a breakthrough for children with peanut allergies: immunotherapy that when taken daily fo ...
DEC 15, 2020
Immunology
The Possibility of Improving an Older Adult's Response to Vaccines
DEC 15, 2020
The Possibility of Improving an Older Adult's Response to Vaccines
A recent study published in the eLife journal examined how they can improve older adults' responses to vaccines ...
JAN 20, 2021
Immunology
Gut Bacteria's Poison Arrows Exposed
JAN 20, 2021
Gut Bacteria's Poison Arrows Exposed
Bacteria armed with toxin bombs and excruciating abdominal pains caused by raging inflammation in the gut. While the cau ...
Loading Comments...